Atossa Genetics to Host Conference Call to Present Additional Findings from its Phase 1 Study of Oral Endoxifen Thursday February 1, 2018 at 4:30 pm EST
Stock Information for Atossa Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.